Related Experiment Video
Updated: Jun 25, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
[Role of CD4+CD25+Foxp3+ regulatory T cells in type 2 diabetic nephropathy]
Jing Xu1, Hong-li Su, Jun-hong Wang
1Department of Endocrinology, Second Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an 710004, China. xujingj dey85@163.com
Objective:
To investigate the role of CD4+CD25+Foxp3+ regulatory T cells (Treg) in type 2 diabetic nephropathy and provide new clues for prevention and treatment of type 2 diabetic nephropathy.
Methods:
Flow cytometry was used to analyze the expression rate of CD4+CD25+Foxp3+ Treg cells in 60 patients with type 2 diabetes and 15 normal subjects.
Results:
No significant difference was found in the expression rate of CD4+CD25+Foxp3+ Treg cells between the control group and the type 2 diabetic patients. In the type 2 diabetic patients with microalbuminuria and macroalbuminuria, the expression of CD4+CD25+Foxp3+ Treg cells was significantly lowered in comparison with that in the control group (P<0.05), and patients with macroalbuminuria showed significantly lower expression of CD4+CD25+Foxp3+ Treg cells than the microalbuminuric patinets (P<0.05). Significant inverse correlations were noted between the disease course and the expression of CD4+CD25+Foxp3+ Treg cells and between the urinary albumin excretion rate (UAER) and the expression of CD4+CD25+Foxp3+ Treg cells.
Conclusion:
CD4+CD25+Foxp3+ Treg cells may play a role in the occurrence and development of type 2 diabetic nephropathy.
Insights
Regulatory T cells (Treg) are reduced in type 2 diabetic nephropathy, particularly in advanced stages with macroalbuminuria. Lower Treg cell expression correlates with disease severity and urinary albumin excretion, suggesting a role in disease progression.
Area of Science:
- Immunology
- Nephrology
- Endocrinology
Background:
- Type 2 diabetic nephropathy (T2DN) is a major complication of type 2 diabetes.
- Regulatory T cells (Treg) play a crucial role in immune homeostasis and preventing autoimmunity.
- The specific role of Treg cells in T2DN pathogenesis remains incompletely understood.
Purpose of the Study:
- To investigate the involvement of CD4+CD25+Foxp3+ Treg cells in T2DN.
- To explore potential therapeutic targets for T2DN prevention and treatment.
Main Methods:
- Flow cytometry was employed to quantify CD4+CD25+Foxp3+ Treg cell expression rates.
- Analysis included 60 patients with T2DN and 15 healthy controls.
- Patients were stratified based on urinary albumin excretion (microalbuminuria vs. macroalbuminuria).
Main Results:
- No significant difference in Treg cell expression was observed between all T2DN patients and controls.
- Treg cell expression was significantly lower in T2DN patients with microalbuminuria and macroalbuminuria compared to controls.
- Patients with macroalbuminuria exhibited significantly lower Treg cell expression than those with microalbuminuria.
- A significant inverse correlation was found between Treg cell expression and disease duration.
- Urinary albumin excretion rate (UAER) showed a significant inverse correlation with Treg cell expression.
Conclusions:
- CD4+CD25+Foxp3+ Treg cells are implicated in the development and progression of type 2 diabetic nephropathy.
- Reduced Treg cell function may contribute to the pathogenesis of T2DN.
- Modulating Treg cell activity could be a potential therapeutic strategy for T2DN.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Diabetic Nephropathy
Diabetes Mellitus: Type 2 and Gestational

